1218 results found
Over the last 10 years NHMRC has invested more than $191 million in research on malaria1
Dr Romain Ragonnet is a Senior Research Fellow in the Epidemiological Modelling Unit at Monash University. Dr Ragonnet specialises in the mathematical modelling of tuberculosis (TB) and COVID-19, and his notable contributions include the first-ever quantification of TB mortality and self-recovery rates. Dr Ragonnet has advised various governments of lower-middle-income countries in the Asia-Pacific region to assist the local control of TB and COVID-19. He also initiated and led multiple cross-disciplinary collaborations, creating a strong network of world-leading experts that spans mathematics, medical ethics, biostatistics, economics, and clinical trials.
Dr Jeffrey Liddell from the University of Melbourne is a mid-career neurobiologist, with an interest in neurodegenerative diseases and understanding their underlying causes.
The National Health and Medical Research Council (NHMRC) remains committed to supporting dementia research in Australia following the end of the Australian Government's Boosting Dementia Research Initiative (BDRI).
National Health and Medical Research Council (NHMRC) administers Medical Research Future Fund (MRFF) grants. Organisations can apply to NHMRC to become an MRFF Eligible Organisation (MRFF EO). This will allow them to be separately identified in NHMRC's grant management system and to apply for MRFF grant funding.
More than 400,000 Australians are living with dementia. It is Australia's second overall leading cause of burden of disease in injury, behind coronary heart disease.1 A long-term approach to the diagnosis and treatment of dementia is essential for Australia's social and economic wellbeing.
Associate Professor Dina LoGiudice is a geriatrician and clinical researcher with a special interest in dementia and ageing well. For close to two decades, she has been studying the impacts of ageing and dementia in Aboriginal and Torres Strait Islander communities.
Having practised as a hospital pharmacist by day and a residential aged care pharmacist by night, Dr Lisa Pont naturally began to think about how pharmacists could work differently as part of her research.
Professor Robert Gilchrist is a part of a bench-to-bedside research success story, innovating existing infertility treatments to offer a less invasive and cheaper alternative to in-vitro fertilisation (IVF).
Immunologist Dr Jason Waithman leads the Cancer Immunotherapy Group at the Telethon Kids Institute in Western Australia.
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
Discover how Professor Stuart Kinner's world first study on the health of justice-involved young people is uncovering critical insights into the risks and causes of premature death among vulnerable young Australians.
NHMRC seeks to maximise the reporting of impacts arising from the research that it funds and from its other activities, but it cannot undertake this impact reporting on its own.
Professor Richard Lewis and his team from the Institute of Molecular Bioscience at University of Queensland made a notable discovery early in their research after a lab assistant observed one could milk cone snails for venom much more quickly if you gave them 'a poke or two'.